 HOUSTON, Jan. 06, 2022 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that the company will present at H.C. Wainwright BioConnect and participate in Biotech Showcase and BIO Partnering JPM. All three events will be held virtually and are scheduled alongside the J.P. Morgan 40th Annual Healthcare Conference 2022. 